Schistosomiasis News and Research

RSS

Schistosomiaisis is a disease caused by parasitic worms. You become infected when your skin comes in contact with contaminated freshwater in which certain types of snails that carry schistosomes are living. Schistosomiasis is not found in the United States, but more than 200 million people are infected worldwide.

Innovative molecular biology technique used to identify targets for Schistosoma mansoni vaccine candidates

Researchers in Brazil have used an innovative technique in molecular biology to identify targets for candidate vaccines against Schistosoma mansoni, the parasite that causes schistosomiasis.

2 Apr 2024

New compound shows promise as a more effective treatment for schistosomiasis

A newly developed compound is showing promise in animal studies as a more effective treatment for human schistosomiasis, an understudied tropical disease caused by parasitic worms.

25 Mar 2024

New study highlights the urgent need for typhoid vaccination in sub-Saharan Africa

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health.

12 Mar 2024

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

9 Nov 2023

AI-powered Schistoscope could revolutionize diagnosis of parasitic disease

Schistosomiasis, a parasitic disease affecting millions worldwide, poses a significant public health and economic burden, particularly in impoverished regions.

8 Aug 2023

Researchers uncover novel targets for treatment of schistosomiasis

The worms that cause schistosomiasis (Schistosoma mansoni) are unusual in several ways, especially the fact that male and female adults must stay paired together throughout their lives for reproduction to be successful.

21 Jul 2023

Pandemic paralysis: COVID-19 halts neglected tropical disease campaigns, study reveals solutions

In a recent study published in the journal PLoS Neglected Tropical Diseases, researchers evaluated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on mass drug administration (MDA) programming. They also provided solutions by neglected tropical disease (NTD) stakeholders for the relaunch of MDA implementation activities.

28 Jun 2023

Crystal engineering strategy could make medicines more soluble and palatable for children

Research conducted at University of Limerick in Ireland has shown that crystal engineering can improve access to a drug used in the treatment of a tropical disease affecting millions worldwide.

3 Apr 2023

Promoting the One Health approach could greatly improve human-animal health and environmental integrity

Researchers pursued contemporary evidence of how One Health approaches could improve health security at a global scale against unprecedented health hazards, such as the one posed by the coronavirus disease 2019 (COVID-19) pandemic.

24 Jan 2023

IVI and Lemonex sign MOU to join forces on vaccine development

The International Vaccine Institute announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development.

10 Nov 2022

The potential influence of pre-existing parasitic infections on COVID-19 morbidity

The study reveals that countries with a high malaria prevalence have a lower incidence of COVID-19.

13 Oct 2022

Research project on female schistosomiasis receives record-high funding

Female genital schistosomiasis (FGS) is a disease that affects millions of women, but it is often misdiagnosed as cancer or a venereal disease. This leads to unnecessary surgery, social sanctions and ruined lives.

12 Oct 2022

Modified TB vaccine could help treat non-muscle invasive bladder cancer

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

22 Aug 2022

IVI successfully completes the '2022 Introductory Course for Biologics Development and Manufacturing'

The International Vaccine Institute (IVI) successfully completed the '2022 Introductory Course for Biologics Development and Manufacturing' on July 29 to train 106 participants from 24 low- and middle-income countries (LMICs) and 32 from the Republic of Korea.

29 Jul 2022

Debunking some misconceptions surrounding female genital schistosomiasis

Female genital schistosomiasis - FGS - affects an estimated 56 million women in Sub-Saharan Africa. But not much is known about how this debilitating condition affects women in Sub-Saharan Africa, despite its prevalence.

27 Jul 2022

Texas Biomed professor to join $577 million effort for developing antivirals against COVID-19 and other viruses

As the coronavirus waves keep coming and cases are on the rise once again, the National Institutes of Health (NIH) recently launched a $577 million effort to develop antivirals against COVID-19 and other viruses with high pandemic potential.

15 Jul 2022

IVI and partners to provide two doses of oral vaccine to 100,000 people at risk of cholera in Ethiopia

The International Vaccine Institute, in collaboration with LG Electronics, the Ethiopian government led by Armauer Hansen Research Institute, and the Ethiopian Public Health Institute, will vaccinate 40,000 people against cholera in May to support prevention of the disease in Ethiopia.

13 May 2022

SK bioscience's typhoid vaccine licensed for export by Korean Ministry of Food and Drug Safety

The International Vaccine Institute (IVI) and SK bioscience announced today that SK bioscience obtained an export license from the Korean Ministry of Food and Drug Safety for SK's typhoid vaccine 'SKYTyphoid' which they jointly developed.

12 May 2022

Q&A: COVID-19 pandemic has widened gender inequities in health

Health inequalities facing women and girls, already stark before the onset of COVID-19, have widened glaringly during the pandemic. Lockdowns restricted access to sexual and reproductive health services, increased violence against women, and interrupted girls’ education.

9 May 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022